Jusayan, Rue Grayson P.

HRN: 24-59-18  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/19/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
01/19/2025
01/25/2025
IV
350
Q6
Pcap
Waiting Final Action 
01/21/2025
CEFUROXIME 750MG (VIAL)
01/21/2025
01/28/2025
IV
250mh
Q8
Pcap C
Waiting Final Action 
01/22/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
01/22/2025
01/29/2025
IV
105mg
Q24H
PCAP C
Waiting Final Action 
01/23/2025
CEFTRIAXONE 1G (VIAL)
01/23/2025
01/29/2025
IV DRIP
700mg
OD
PCAP
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: